Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...
As the second leading cause of death globally, cancer is a worldwide health crisis, particularly as life expectancies continue to increase. In its final stages, cancer spreads throughout the body in a ...
Morning Overview on MSN
Scientists uncover genetic switch that makes pancreatic cancer chemo-proof
Researchers at Duke-NUS Medical School have identified a molecular switch controlled by the protein GATA6 that determines whether pancreatic cancer cells respond to chemotherapy or become resistant.
Cancer research continues to evolve as scientists strive to unravel the complexities of tumor biology, molecular signaling, and metabolic adaptations.
Scientists at Duke-NUS Medical School have identified a molecular “switch” that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results